Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/cdsco-drafting-new-norms-for-financial-compensation-mahim-pratap-singh-16654/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/cdsco-drafting-new-norms-for-financial-compensation-mahim-pratap-singh-16654/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/cdsco-drafting-new-norms-for-financial-compensation-mahim-pratap-singh-16654/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/cdsco-drafting-new-norms-for-financial-compensation-mahim-pratap-singh-16654/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6813ee92c35b0-trace').style.display = (document.getElementById('cakeErr6813ee92c35b0-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6813ee92c35b0-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6813ee92c35b0-code').style.display = (document.getElementById('cakeErr6813ee92c35b0-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6813ee92c35b0-context').style.display = (document.getElementById('cakeErr6813ee92c35b0-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6813ee92c35b0-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr6813ee92c35b0-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 16526,
		&#039;title&#039; =&gt; &#039;CDSCO drafting new norms for financial compensation-Mahim Pratap Singh&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu&lt;br /&gt;
&lt;br /&gt;
In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.&lt;br /&gt;
&lt;br /&gt;
The total amount paid in compensation in all the 16 cases adds up to Rs. 34.88 lakh, with the highest amount being Rs. 5 lakh, and the lowest being Rs. 50,000.&lt;br /&gt;
&lt;br /&gt;
This makes 2011 only the second year, for which data are available, when any compensation was paid in cases of deaths caused during medicine trials, the previous year being 2010, when 22 such cases were compensated.&lt;br /&gt;
&lt;br /&gt;
According to documents available with The Hindu , the largest amount in compensation was paid by Sun Pharma. The company paid Rs. 15 lakh in compensation in five cases (Rs. 3 lakh each).&lt;br /&gt;
&lt;br /&gt;
Next in line was US-based Clinical Research Organization (CRO) ICON PLC, (6.52 lakh in three cases), followed by Pfizer Inc (6.5 lakh in two cases) and German pharma and medical-care giant Fresenius (Rs. 1 lakh in two cases).&lt;br /&gt;
&lt;br /&gt;
Delhi-based CRO Apothecaries (Rs. 2.16 lakh), Multinational Clinical Research bigwig Lambda (Rs. 2 lakh), French firm Sanofi (Rs. 1 lakh), and Indian firm Veeda Clinical Research (Rs. 50,000), each paid compensation to one case of death.&lt;br /&gt;
&lt;br /&gt;
The information was provided by the office of the Drug Controller General (India) to medical rights activist, Anand Rai.&lt;br /&gt;
&lt;br /&gt;
The information provided by the DCG (I) doesn&amp;rsquo;t tell if the compensation was paid by the foreign firms or their Indian subsidiaries.&lt;br /&gt;
&lt;br /&gt;
According to official data, between January 2007 and January 2012, Serious Adverse Events (SAEs) during medicine trials killed 2193 people all across India.&lt;br /&gt;
&lt;br /&gt;
The year-wise break-up of the deaths are: 132 (2007), 288 (2008), 637 (2009), 688 (2010), 438 (2011) and 30 (January, 2012).&lt;br /&gt;
&lt;br /&gt;
However, compensation was provided only to 22 victims in 2010 and 16 in 2011.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;It is shocking that only 3 per cent of the cases have been compensated. It is a mockery of the human rights of trial subjects in India. But sadly, the Central Drugs Standard Control Organization&amp;rsquo;s (CDSCO&amp;rsquo;s) new draft guidelines on financial compensation only address part of the problem,&amp;rdquo; says Dr. Rai, who secured the information under the Right to Information Act.&lt;br /&gt;
&lt;br /&gt;
At present, financial compensation isn&amp;rsquo;t mandated by law in India, and is only mentioned as a Good Clinical Practice (GCP) in paragraph 2.4.7 of the Indian Council of Medical Research&amp;rsquo;s GCP Guidelines for Clinical Trials in India.&lt;br /&gt;
&lt;br /&gt;
The CDSCO&amp;rsquo;s new draft guidelines for financial compensation seek to fill this major gap in the existing Drugs and Cosmetic Act, 1940.&lt;br /&gt;
&lt;br /&gt;
The total amount paid in compensation in all the 16 cases in 2011 adds up to Rs. 34.88 lakh&lt;br /&gt;
&lt;br /&gt;
Sun Pharma paid Rs. 15 lakh in compensation in five cases of Rs. 3 lakh each&lt;br /&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu, 19 August, 2012, http://www.thehindu.com/todays-paper/tp-national/article3793837.ece&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;cdsco-drafting-new-norms-for-financial-compensation-mahim-pratap-singh-16654&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 16654,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 16526,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | CDSCO drafting new norms for financial compensation-Mahim Pratap Singh&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Law and Justice,medicines,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Hindu

In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.

The total amount paid in compensation in all the 16 cases...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu&lt;br /&gt;&lt;br /&gt;In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.&lt;br /&gt;&lt;br /&gt;The total amount paid in compensation in all the 16 cases adds up to Rs. 34.88 lakh, with the highest amount being Rs. 5 lakh, and the lowest being Rs. 50,000.&lt;br /&gt;&lt;br /&gt;This makes 2011 only the second year, for which data are available, when any compensation was paid in cases of deaths caused during medicine trials, the previous year being 2010, when 22 such cases were compensated.&lt;br /&gt;&lt;br /&gt;According to documents available with The Hindu , the largest amount in compensation was paid by Sun Pharma. The company paid Rs. 15 lakh in compensation in five cases (Rs. 3 lakh each).&lt;br /&gt;&lt;br /&gt;Next in line was US-based Clinical Research Organization (CRO) ICON PLC, (6.52 lakh in three cases), followed by Pfizer Inc (6.5 lakh in two cases) and German pharma and medical-care giant Fresenius (Rs. 1 lakh in two cases).&lt;br /&gt;&lt;br /&gt;Delhi-based CRO Apothecaries (Rs. 2.16 lakh), Multinational Clinical Research bigwig Lambda (Rs. 2 lakh), French firm Sanofi (Rs. 1 lakh), and Indian firm Veeda Clinical Research (Rs. 50,000), each paid compensation to one case of death.&lt;br /&gt;&lt;br /&gt;The information was provided by the office of the Drug Controller General (India) to medical rights activist, Anand Rai.&lt;br /&gt;&lt;br /&gt;The information provided by the DCG (I) doesn&amp;rsquo;t tell if the compensation was paid by the foreign firms or their Indian subsidiaries.&lt;br /&gt;&lt;br /&gt;According to official data, between January 2007 and January 2012, Serious Adverse Events (SAEs) during medicine trials killed 2193 people all across India.&lt;br /&gt;&lt;br /&gt;The year-wise break-up of the deaths are: 132 (2007), 288 (2008), 637 (2009), 688 (2010), 438 (2011) and 30 (January, 2012).&lt;br /&gt;&lt;br /&gt;However, compensation was provided only to 22 victims in 2010 and 16 in 2011.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;It is shocking that only 3 per cent of the cases have been compensated. It is a mockery of the human rights of trial subjects in India. But sadly, the Central Drugs Standard Control Organization&amp;rsquo;s (CDSCO&amp;rsquo;s) new draft guidelines on financial compensation only address part of the problem,&amp;rdquo; says Dr. Rai, who secured the information under the Right to Information Act.&lt;br /&gt;&lt;br /&gt;At present, financial compensation isn&amp;rsquo;t mandated by law in India, and is only mentioned as a Good Clinical Practice (GCP) in paragraph 2.4.7 of the Indian Council of Medical Research&amp;rsquo;s GCP Guidelines for Clinical Trials in India.&lt;br /&gt;&lt;br /&gt;The CDSCO&amp;rsquo;s new draft guidelines for financial compensation seek to fill this major gap in the existing Drugs and Cosmetic Act, 1940.&lt;br /&gt;&lt;br /&gt;The total amount paid in compensation in all the 16 cases in 2011 adds up to Rs. 34.88 lakh&lt;br /&gt;&lt;br /&gt;Sun Pharma paid Rs. 15 lakh in compensation in five cases of Rs. 3 lakh each&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 16526,
	&#039;title&#039; =&gt; &#039;CDSCO drafting new norms for financial compensation-Mahim Pratap Singh&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu&lt;br /&gt;
&lt;br /&gt;
In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.&lt;br /&gt;
&lt;br /&gt;
The total amount paid in compensation in all the 16 cases adds up to Rs. 34.88 lakh, with the highest amount being Rs. 5 lakh, and the lowest being Rs. 50,000.&lt;br /&gt;
&lt;br /&gt;
This makes 2011 only the second year, for which data are available, when any compensation was paid in cases of deaths caused during medicine trials, the previous year being 2010, when 22 such cases were compensated.&lt;br /&gt;
&lt;br /&gt;
According to documents available with The Hindu , the largest amount in compensation was paid by Sun Pharma. The company paid Rs. 15 lakh in compensation in five cases (Rs. 3 lakh each).&lt;br /&gt;
&lt;br /&gt;
Next in line was US-based Clinical Research Organization (CRO) ICON PLC, (6.52 lakh in three cases), followed by Pfizer Inc (6.5 lakh in two cases) and German pharma and medical-care giant Fresenius (Rs. 1 lakh in two cases).&lt;br /&gt;
&lt;br /&gt;
Delhi-based CRO Apothecaries (Rs. 2.16 lakh), Multinational Clinical Research bigwig Lambda (Rs. 2 lakh), French firm Sanofi (Rs. 1 lakh), and Indian firm Veeda Clinical Research (Rs. 50,000), each paid compensation to one case of death.&lt;br /&gt;
&lt;br /&gt;
The information was provided by the office of the Drug Controller General (India) to medical rights activist, Anand Rai.&lt;br /&gt;
&lt;br /&gt;
The information provided by the DCG (I) doesn&amp;rsquo;t tell if the compensation was paid by the foreign firms or their Indian subsidiaries.&lt;br /&gt;
&lt;br /&gt;
According to official data, between January 2007 and January 2012, Serious Adverse Events (SAEs) during medicine trials killed 2193 people all across India.&lt;br /&gt;
&lt;br /&gt;
The year-wise break-up of the deaths are: 132 (2007), 288 (2008), 637 (2009), 688 (2010), 438 (2011) and 30 (January, 2012).&lt;br /&gt;
&lt;br /&gt;
However, compensation was provided only to 22 victims in 2010 and 16 in 2011.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;It is shocking that only 3 per cent of the cases have been compensated. It is a mockery of the human rights of trial subjects in India. But sadly, the Central Drugs Standard Control Organization&amp;rsquo;s (CDSCO&amp;rsquo;s) new draft guidelines on financial compensation only address part of the problem,&amp;rdquo; says Dr. Rai, who secured the information under the Right to Information Act.&lt;br /&gt;
&lt;br /&gt;
At present, financial compensation isn&amp;rsquo;t mandated by law in India, and is only mentioned as a Good Clinical Practice (GCP) in paragraph 2.4.7 of the Indian Council of Medical Research&amp;rsquo;s GCP Guidelines for Clinical Trials in India.&lt;br /&gt;
&lt;br /&gt;
The CDSCO&amp;rsquo;s new draft guidelines for financial compensation seek to fill this major gap in the existing Drugs and Cosmetic Act, 1940.&lt;br /&gt;
&lt;br /&gt;
The total amount paid in compensation in all the 16 cases in 2011 adds up to Rs. 34.88 lakh&lt;br /&gt;
&lt;br /&gt;
Sun Pharma paid Rs. 15 lakh in compensation in five cases of Rs. 3 lakh each&lt;br /&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu, 19 August, 2012, http://www.thehindu.com/todays-paper/tp-national/article3793837.ece&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;cdsco-drafting-new-norms-for-financial-compensation-mahim-pratap-singh-16654&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 16654,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 16526
$metaTitle = &#039;LATEST NEWS UPDATES | CDSCO drafting new norms for financial compensation-Mahim Pratap Singh&#039;
$metaKeywords = &#039;Law and Justice,medicines,Health&#039;
$metaDesc = &#039;
-The Hindu

In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.

The total amount paid in compensation in all the 16 cases...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu&lt;br /&gt;&lt;br /&gt;In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.&lt;br /&gt;&lt;br /&gt;The total amount paid in compensation in all the 16 cases adds up to Rs. 34.88 lakh, with the highest amount being Rs. 5 lakh, and the lowest being Rs. 50,000.&lt;br /&gt;&lt;br /&gt;This makes 2011 only the second year, for which data are available, when any compensation was paid in cases of deaths caused during medicine trials, the previous year being 2010, when 22 such cases were compensated.&lt;br /&gt;&lt;br /&gt;According to documents available with The Hindu , the largest amount in compensation was paid by Sun Pharma. The company paid Rs. 15 lakh in compensation in five cases (Rs. 3 lakh each).&lt;br /&gt;&lt;br /&gt;Next in line was US-based Clinical Research Organization (CRO) ICON PLC, (6.52 lakh in three cases), followed by Pfizer Inc (6.5 lakh in two cases) and German pharma and medical-care giant Fresenius (Rs. 1 lakh in two cases).&lt;br /&gt;&lt;br /&gt;Delhi-based CRO Apothecaries (Rs. 2.16 lakh), Multinational Clinical Research bigwig Lambda (Rs. 2 lakh), French firm Sanofi (Rs. 1 lakh), and Indian firm Veeda Clinical Research (Rs. 50,000), each paid compensation to one case of death.&lt;br /&gt;&lt;br /&gt;The information was provided by the office of the Drug Controller General (India) to medical rights activist, Anand Rai.&lt;br /&gt;&lt;br /&gt;The information provided by the DCG (I) doesn&amp;rsquo;t tell if the compensation was paid by the foreign firms or their Indian subsidiaries.&lt;br /&gt;&lt;br /&gt;According to official data, between January 2007 and January 2012, Serious Adverse Events (SAEs) during medicine trials killed 2193 people all across India.&lt;br /&gt;&lt;br /&gt;The year-wise break-up of the deaths are: 132 (2007), 288 (2008), 637 (2009), 688 (2010), 438 (2011) and 30 (January, 2012).&lt;br /&gt;&lt;br /&gt;However, compensation was provided only to 22 victims in 2010 and 16 in 2011.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;It is shocking that only 3 per cent of the cases have been compensated. It is a mockery of the human rights of trial subjects in India. But sadly, the Central Drugs Standard Control Organization&amp;rsquo;s (CDSCO&amp;rsquo;s) new draft guidelines on financial compensation only address part of the problem,&amp;rdquo; says Dr. Rai, who secured the information under the Right to Information Act.&lt;br /&gt;&lt;br /&gt;At present, financial compensation isn&amp;rsquo;t mandated by law in India, and is only mentioned as a Good Clinical Practice (GCP) in paragraph 2.4.7 of the Indian Council of Medical Research&amp;rsquo;s GCP Guidelines for Clinical Trials in India.&lt;br /&gt;&lt;br /&gt;The CDSCO&amp;rsquo;s new draft guidelines for financial compensation seek to fill this major gap in the existing Drugs and Cosmetic Act, 1940.&lt;br /&gt;&lt;br /&gt;The total amount paid in compensation in all the 16 cases in 2011 adds up to Rs. 34.88 lakh&lt;br /&gt;&lt;br /&gt;Sun Pharma paid Rs. 15 lakh in compensation in five cases of Rs. 3 lakh each&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/cdsco-drafting-new-norms-for-financial-compensation-mahim-pratap-singh-16654.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | CDSCO drafting new norms for financial compensation-Mahim Pratap Singh | Im4change.org</title>
    <meta name="description" content="
-The Hindu

In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.

The total amount paid in compensation in all the 16 cases..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>CDSCO drafting new norms for financial compensation-Mahim Pratap Singh</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Hindu<br /><br />In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.<br /><br />The total amount paid in compensation in all the 16 cases adds up to Rs. 34.88 lakh, with the highest amount being Rs. 5 lakh, and the lowest being Rs. 50,000.<br /><br />This makes 2011 only the second year, for which data are available, when any compensation was paid in cases of deaths caused during medicine trials, the previous year being 2010, when 22 such cases were compensated.<br /><br />According to documents available with The Hindu , the largest amount in compensation was paid by Sun Pharma. The company paid Rs. 15 lakh in compensation in five cases (Rs. 3 lakh each).<br /><br />Next in line was US-based Clinical Research Organization (CRO) ICON PLC, (6.52 lakh in three cases), followed by Pfizer Inc (6.5 lakh in two cases) and German pharma and medical-care giant Fresenius (Rs. 1 lakh in two cases).<br /><br />Delhi-based CRO Apothecaries (Rs. 2.16 lakh), Multinational Clinical Research bigwig Lambda (Rs. 2 lakh), French firm Sanofi (Rs. 1 lakh), and Indian firm Veeda Clinical Research (Rs. 50,000), each paid compensation to one case of death.<br /><br />The information was provided by the office of the Drug Controller General (India) to medical rights activist, Anand Rai.<br /><br />The information provided by the DCG (I) doesn&rsquo;t tell if the compensation was paid by the foreign firms or their Indian subsidiaries.<br /><br />According to official data, between January 2007 and January 2012, Serious Adverse Events (SAEs) during medicine trials killed 2193 people all across India.<br /><br />The year-wise break-up of the deaths are: 132 (2007), 288 (2008), 637 (2009), 688 (2010), 438 (2011) and 30 (January, 2012).<br /><br />However, compensation was provided only to 22 victims in 2010 and 16 in 2011.<br /><br />&ldquo;It is shocking that only 3 per cent of the cases have been compensated. It is a mockery of the human rights of trial subjects in India. But sadly, the Central Drugs Standard Control Organization&rsquo;s (CDSCO&rsquo;s) new draft guidelines on financial compensation only address part of the problem,&rdquo; says Dr. Rai, who secured the information under the Right to Information Act.<br /><br />At present, financial compensation isn&rsquo;t mandated by law in India, and is only mentioned as a Good Clinical Practice (GCP) in paragraph 2.4.7 of the Indian Council of Medical Research&rsquo;s GCP Guidelines for Clinical Trials in India.<br /><br />The CDSCO&rsquo;s new draft guidelines for financial compensation seek to fill this major gap in the existing Drugs and Cosmetic Act, 1940.<br /><br />The total amount paid in compensation in all the 16 cases in 2011 adds up to Rs. 34.88 lakh<br /><br />Sun Pharma paid Rs. 15 lakh in compensation in five cases of Rs. 3 lakh each<br /><br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6813ee92c35b0-trace').style.display = (document.getElementById('cakeErr6813ee92c35b0-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6813ee92c35b0-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6813ee92c35b0-code').style.display = (document.getElementById('cakeErr6813ee92c35b0-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6813ee92c35b0-context').style.display = (document.getElementById('cakeErr6813ee92c35b0-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6813ee92c35b0-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr6813ee92c35b0-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 16526,
		&#039;title&#039; =&gt; &#039;CDSCO drafting new norms for financial compensation-Mahim Pratap Singh&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu&lt;br /&gt;
&lt;br /&gt;
In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.&lt;br /&gt;
&lt;br /&gt;
The total amount paid in compensation in all the 16 cases adds up to Rs. 34.88 lakh, with the highest amount being Rs. 5 lakh, and the lowest being Rs. 50,000.&lt;br /&gt;
&lt;br /&gt;
This makes 2011 only the second year, for which data are available, when any compensation was paid in cases of deaths caused during medicine trials, the previous year being 2010, when 22 such cases were compensated.&lt;br /&gt;
&lt;br /&gt;
According to documents available with The Hindu , the largest amount in compensation was paid by Sun Pharma. The company paid Rs. 15 lakh in compensation in five cases (Rs. 3 lakh each).&lt;br /&gt;
&lt;br /&gt;
Next in line was US-based Clinical Research Organization (CRO) ICON PLC, (6.52 lakh in three cases), followed by Pfizer Inc (6.5 lakh in two cases) and German pharma and medical-care giant Fresenius (Rs. 1 lakh in two cases).&lt;br /&gt;
&lt;br /&gt;
Delhi-based CRO Apothecaries (Rs. 2.16 lakh), Multinational Clinical Research bigwig Lambda (Rs. 2 lakh), French firm Sanofi (Rs. 1 lakh), and Indian firm Veeda Clinical Research (Rs. 50,000), each paid compensation to one case of death.&lt;br /&gt;
&lt;br /&gt;
The information was provided by the office of the Drug Controller General (India) to medical rights activist, Anand Rai.&lt;br /&gt;
&lt;br /&gt;
The information provided by the DCG (I) doesn&amp;rsquo;t tell if the compensation was paid by the foreign firms or their Indian subsidiaries.&lt;br /&gt;
&lt;br /&gt;
According to official data, between January 2007 and January 2012, Serious Adverse Events (SAEs) during medicine trials killed 2193 people all across India.&lt;br /&gt;
&lt;br /&gt;
The year-wise break-up of the deaths are: 132 (2007), 288 (2008), 637 (2009), 688 (2010), 438 (2011) and 30 (January, 2012).&lt;br /&gt;
&lt;br /&gt;
However, compensation was provided only to 22 victims in 2010 and 16 in 2011.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;It is shocking that only 3 per cent of the cases have been compensated. It is a mockery of the human rights of trial subjects in India. But sadly, the Central Drugs Standard Control Organization&amp;rsquo;s (CDSCO&amp;rsquo;s) new draft guidelines on financial compensation only address part of the problem,&amp;rdquo; says Dr. Rai, who secured the information under the Right to Information Act.&lt;br /&gt;
&lt;br /&gt;
At present, financial compensation isn&amp;rsquo;t mandated by law in India, and is only mentioned as a Good Clinical Practice (GCP) in paragraph 2.4.7 of the Indian Council of Medical Research&amp;rsquo;s GCP Guidelines for Clinical Trials in India.&lt;br /&gt;
&lt;br /&gt;
The CDSCO&amp;rsquo;s new draft guidelines for financial compensation seek to fill this major gap in the existing Drugs and Cosmetic Act, 1940.&lt;br /&gt;
&lt;br /&gt;
The total amount paid in compensation in all the 16 cases in 2011 adds up to Rs. 34.88 lakh&lt;br /&gt;
&lt;br /&gt;
Sun Pharma paid Rs. 15 lakh in compensation in five cases of Rs. 3 lakh each&lt;br /&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu, 19 August, 2012, http://www.thehindu.com/todays-paper/tp-national/article3793837.ece&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;cdsco-drafting-new-norms-for-financial-compensation-mahim-pratap-singh-16654&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 16654,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 16526,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | CDSCO drafting new norms for financial compensation-Mahim Pratap Singh&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Law and Justice,medicines,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Hindu

In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.

The total amount paid in compensation in all the 16 cases...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu&lt;br /&gt;&lt;br /&gt;In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.&lt;br /&gt;&lt;br /&gt;The total amount paid in compensation in all the 16 cases adds up to Rs. 34.88 lakh, with the highest amount being Rs. 5 lakh, and the lowest being Rs. 50,000.&lt;br /&gt;&lt;br /&gt;This makes 2011 only the second year, for which data are available, when any compensation was paid in cases of deaths caused during medicine trials, the previous year being 2010, when 22 such cases were compensated.&lt;br /&gt;&lt;br /&gt;According to documents available with The Hindu , the largest amount in compensation was paid by Sun Pharma. The company paid Rs. 15 lakh in compensation in five cases (Rs. 3 lakh each).&lt;br /&gt;&lt;br /&gt;Next in line was US-based Clinical Research Organization (CRO) ICON PLC, (6.52 lakh in three cases), followed by Pfizer Inc (6.5 lakh in two cases) and German pharma and medical-care giant Fresenius (Rs. 1 lakh in two cases).&lt;br /&gt;&lt;br /&gt;Delhi-based CRO Apothecaries (Rs. 2.16 lakh), Multinational Clinical Research bigwig Lambda (Rs. 2 lakh), French firm Sanofi (Rs. 1 lakh), and Indian firm Veeda Clinical Research (Rs. 50,000), each paid compensation to one case of death.&lt;br /&gt;&lt;br /&gt;The information was provided by the office of the Drug Controller General (India) to medical rights activist, Anand Rai.&lt;br /&gt;&lt;br /&gt;The information provided by the DCG (I) doesn&amp;rsquo;t tell if the compensation was paid by the foreign firms or their Indian subsidiaries.&lt;br /&gt;&lt;br /&gt;According to official data, between January 2007 and January 2012, Serious Adverse Events (SAEs) during medicine trials killed 2193 people all across India.&lt;br /&gt;&lt;br /&gt;The year-wise break-up of the deaths are: 132 (2007), 288 (2008), 637 (2009), 688 (2010), 438 (2011) and 30 (January, 2012).&lt;br /&gt;&lt;br /&gt;However, compensation was provided only to 22 victims in 2010 and 16 in 2011.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;It is shocking that only 3 per cent of the cases have been compensated. It is a mockery of the human rights of trial subjects in India. But sadly, the Central Drugs Standard Control Organization&amp;rsquo;s (CDSCO&amp;rsquo;s) new draft guidelines on financial compensation only address part of the problem,&amp;rdquo; says Dr. Rai, who secured the information under the Right to Information Act.&lt;br /&gt;&lt;br /&gt;At present, financial compensation isn&amp;rsquo;t mandated by law in India, and is only mentioned as a Good Clinical Practice (GCP) in paragraph 2.4.7 of the Indian Council of Medical Research&amp;rsquo;s GCP Guidelines for Clinical Trials in India.&lt;br /&gt;&lt;br /&gt;The CDSCO&amp;rsquo;s new draft guidelines for financial compensation seek to fill this major gap in the existing Drugs and Cosmetic Act, 1940.&lt;br /&gt;&lt;br /&gt;The total amount paid in compensation in all the 16 cases in 2011 adds up to Rs. 34.88 lakh&lt;br /&gt;&lt;br /&gt;Sun Pharma paid Rs. 15 lakh in compensation in five cases of Rs. 3 lakh each&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 16526,
	&#039;title&#039; =&gt; &#039;CDSCO drafting new norms for financial compensation-Mahim Pratap Singh&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu&lt;br /&gt;
&lt;br /&gt;
In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.&lt;br /&gt;
&lt;br /&gt;
The total amount paid in compensation in all the 16 cases adds up to Rs. 34.88 lakh, with the highest amount being Rs. 5 lakh, and the lowest being Rs. 50,000.&lt;br /&gt;
&lt;br /&gt;
This makes 2011 only the second year, for which data are available, when any compensation was paid in cases of deaths caused during medicine trials, the previous year being 2010, when 22 such cases were compensated.&lt;br /&gt;
&lt;br /&gt;
According to documents available with The Hindu , the largest amount in compensation was paid by Sun Pharma. The company paid Rs. 15 lakh in compensation in five cases (Rs. 3 lakh each).&lt;br /&gt;
&lt;br /&gt;
Next in line was US-based Clinical Research Organization (CRO) ICON PLC, (6.52 lakh in three cases), followed by Pfizer Inc (6.5 lakh in two cases) and German pharma and medical-care giant Fresenius (Rs. 1 lakh in two cases).&lt;br /&gt;
&lt;br /&gt;
Delhi-based CRO Apothecaries (Rs. 2.16 lakh), Multinational Clinical Research bigwig Lambda (Rs. 2 lakh), French firm Sanofi (Rs. 1 lakh), and Indian firm Veeda Clinical Research (Rs. 50,000), each paid compensation to one case of death.&lt;br /&gt;
&lt;br /&gt;
The information was provided by the office of the Drug Controller General (India) to medical rights activist, Anand Rai.&lt;br /&gt;
&lt;br /&gt;
The information provided by the DCG (I) doesn&amp;rsquo;t tell if the compensation was paid by the foreign firms or their Indian subsidiaries.&lt;br /&gt;
&lt;br /&gt;
According to official data, between January 2007 and January 2012, Serious Adverse Events (SAEs) during medicine trials killed 2193 people all across India.&lt;br /&gt;
&lt;br /&gt;
The year-wise break-up of the deaths are: 132 (2007), 288 (2008), 637 (2009), 688 (2010), 438 (2011) and 30 (January, 2012).&lt;br /&gt;
&lt;br /&gt;
However, compensation was provided only to 22 victims in 2010 and 16 in 2011.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;It is shocking that only 3 per cent of the cases have been compensated. It is a mockery of the human rights of trial subjects in India. But sadly, the Central Drugs Standard Control Organization&amp;rsquo;s (CDSCO&amp;rsquo;s) new draft guidelines on financial compensation only address part of the problem,&amp;rdquo; says Dr. Rai, who secured the information under the Right to Information Act.&lt;br /&gt;
&lt;br /&gt;
At present, financial compensation isn&amp;rsquo;t mandated by law in India, and is only mentioned as a Good Clinical Practice (GCP) in paragraph 2.4.7 of the Indian Council of Medical Research&amp;rsquo;s GCP Guidelines for Clinical Trials in India.&lt;br /&gt;
&lt;br /&gt;
The CDSCO&amp;rsquo;s new draft guidelines for financial compensation seek to fill this major gap in the existing Drugs and Cosmetic Act, 1940.&lt;br /&gt;
&lt;br /&gt;
The total amount paid in compensation in all the 16 cases in 2011 adds up to Rs. 34.88 lakh&lt;br /&gt;
&lt;br /&gt;
Sun Pharma paid Rs. 15 lakh in compensation in five cases of Rs. 3 lakh each&lt;br /&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu, 19 August, 2012, http://www.thehindu.com/todays-paper/tp-national/article3793837.ece&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;cdsco-drafting-new-norms-for-financial-compensation-mahim-pratap-singh-16654&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 16654,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 16526
$metaTitle = &#039;LATEST NEWS UPDATES | CDSCO drafting new norms for financial compensation-Mahim Pratap Singh&#039;
$metaKeywords = &#039;Law and Justice,medicines,Health&#039;
$metaDesc = &#039;
-The Hindu

In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.

The total amount paid in compensation in all the 16 cases...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu&lt;br /&gt;&lt;br /&gt;In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.&lt;br /&gt;&lt;br /&gt;The total amount paid in compensation in all the 16 cases adds up to Rs. 34.88 lakh, with the highest amount being Rs. 5 lakh, and the lowest being Rs. 50,000.&lt;br /&gt;&lt;br /&gt;This makes 2011 only the second year, for which data are available, when any compensation was paid in cases of deaths caused during medicine trials, the previous year being 2010, when 22 such cases were compensated.&lt;br /&gt;&lt;br /&gt;According to documents available with The Hindu , the largest amount in compensation was paid by Sun Pharma. The company paid Rs. 15 lakh in compensation in five cases (Rs. 3 lakh each).&lt;br /&gt;&lt;br /&gt;Next in line was US-based Clinical Research Organization (CRO) ICON PLC, (6.52 lakh in three cases), followed by Pfizer Inc (6.5 lakh in two cases) and German pharma and medical-care giant Fresenius (Rs. 1 lakh in two cases).&lt;br /&gt;&lt;br /&gt;Delhi-based CRO Apothecaries (Rs. 2.16 lakh), Multinational Clinical Research bigwig Lambda (Rs. 2 lakh), French firm Sanofi (Rs. 1 lakh), and Indian firm Veeda Clinical Research (Rs. 50,000), each paid compensation to one case of death.&lt;br /&gt;&lt;br /&gt;The information was provided by the office of the Drug Controller General (India) to medical rights activist, Anand Rai.&lt;br /&gt;&lt;br /&gt;The information provided by the DCG (I) doesn&amp;rsquo;t tell if the compensation was paid by the foreign firms or their Indian subsidiaries.&lt;br /&gt;&lt;br /&gt;According to official data, between January 2007 and January 2012, Serious Adverse Events (SAEs) during medicine trials killed 2193 people all across India.&lt;br /&gt;&lt;br /&gt;The year-wise break-up of the deaths are: 132 (2007), 288 (2008), 637 (2009), 688 (2010), 438 (2011) and 30 (January, 2012).&lt;br /&gt;&lt;br /&gt;However, compensation was provided only to 22 victims in 2010 and 16 in 2011.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;It is shocking that only 3 per cent of the cases have been compensated. It is a mockery of the human rights of trial subjects in India. But sadly, the Central Drugs Standard Control Organization&amp;rsquo;s (CDSCO&amp;rsquo;s) new draft guidelines on financial compensation only address part of the problem,&amp;rdquo; says Dr. Rai, who secured the information under the Right to Information Act.&lt;br /&gt;&lt;br /&gt;At present, financial compensation isn&amp;rsquo;t mandated by law in India, and is only mentioned as a Good Clinical Practice (GCP) in paragraph 2.4.7 of the Indian Council of Medical Research&amp;rsquo;s GCP Guidelines for Clinical Trials in India.&lt;br /&gt;&lt;br /&gt;The CDSCO&amp;rsquo;s new draft guidelines for financial compensation seek to fill this major gap in the existing Drugs and Cosmetic Act, 1940.&lt;br /&gt;&lt;br /&gt;The total amount paid in compensation in all the 16 cases in 2011 adds up to Rs. 34.88 lakh&lt;br /&gt;&lt;br /&gt;Sun Pharma paid Rs. 15 lakh in compensation in five cases of Rs. 3 lakh each&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/cdsco-drafting-new-norms-for-financial-compensation-mahim-pratap-singh-16654.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | CDSCO drafting new norms for financial compensation-Mahim Pratap Singh | Im4change.org</title>
    <meta name="description" content="
-The Hindu

In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.

The total amount paid in compensation in all the 16 cases..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>CDSCO drafting new norms for financial compensation-Mahim Pratap Singh</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Hindu<br /><br />In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.<br /><br />The total amount paid in compensation in all the 16 cases adds up to Rs. 34.88 lakh, with the highest amount being Rs. 5 lakh, and the lowest being Rs. 50,000.<br /><br />This makes 2011 only the second year, for which data are available, when any compensation was paid in cases of deaths caused during medicine trials, the previous year being 2010, when 22 such cases were compensated.<br /><br />According to documents available with The Hindu , the largest amount in compensation was paid by Sun Pharma. The company paid Rs. 15 lakh in compensation in five cases (Rs. 3 lakh each).<br /><br />Next in line was US-based Clinical Research Organization (CRO) ICON PLC, (6.52 lakh in three cases), followed by Pfizer Inc (6.5 lakh in two cases) and German pharma and medical-care giant Fresenius (Rs. 1 lakh in two cases).<br /><br />Delhi-based CRO Apothecaries (Rs. 2.16 lakh), Multinational Clinical Research bigwig Lambda (Rs. 2 lakh), French firm Sanofi (Rs. 1 lakh), and Indian firm Veeda Clinical Research (Rs. 50,000), each paid compensation to one case of death.<br /><br />The information was provided by the office of the Drug Controller General (India) to medical rights activist, Anand Rai.<br /><br />The information provided by the DCG (I) doesn&rsquo;t tell if the compensation was paid by the foreign firms or their Indian subsidiaries.<br /><br />According to official data, between January 2007 and January 2012, Serious Adverse Events (SAEs) during medicine trials killed 2193 people all across India.<br /><br />The year-wise break-up of the deaths are: 132 (2007), 288 (2008), 637 (2009), 688 (2010), 438 (2011) and 30 (January, 2012).<br /><br />However, compensation was provided only to 22 victims in 2010 and 16 in 2011.<br /><br />&ldquo;It is shocking that only 3 per cent of the cases have been compensated. It is a mockery of the human rights of trial subjects in India. But sadly, the Central Drugs Standard Control Organization&rsquo;s (CDSCO&rsquo;s) new draft guidelines on financial compensation only address part of the problem,&rdquo; says Dr. Rai, who secured the information under the Right to Information Act.<br /><br />At present, financial compensation isn&rsquo;t mandated by law in India, and is only mentioned as a Good Clinical Practice (GCP) in paragraph 2.4.7 of the Indian Council of Medical Research&rsquo;s GCP Guidelines for Clinical Trials in India.<br /><br />The CDSCO&rsquo;s new draft guidelines for financial compensation seek to fill this major gap in the existing Drugs and Cosmetic Act, 1940.<br /><br />The total amount paid in compensation in all the 16 cases in 2011 adds up to Rs. 34.88 lakh<br /><br />Sun Pharma paid Rs. 15 lakh in compensation in five cases of Rs. 3 lakh each<br /><br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6813ee92c35b0-trace').style.display = (document.getElementById('cakeErr6813ee92c35b0-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6813ee92c35b0-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6813ee92c35b0-code').style.display = (document.getElementById('cakeErr6813ee92c35b0-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6813ee92c35b0-context').style.display = (document.getElementById('cakeErr6813ee92c35b0-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6813ee92c35b0-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr6813ee92c35b0-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 16526,
		&#039;title&#039; =&gt; &#039;CDSCO drafting new norms for financial compensation-Mahim Pratap Singh&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu&lt;br /&gt;
&lt;br /&gt;
In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.&lt;br /&gt;
&lt;br /&gt;
The total amount paid in compensation in all the 16 cases adds up to Rs. 34.88 lakh, with the highest amount being Rs. 5 lakh, and the lowest being Rs. 50,000.&lt;br /&gt;
&lt;br /&gt;
This makes 2011 only the second year, for which data are available, when any compensation was paid in cases of deaths caused during medicine trials, the previous year being 2010, when 22 such cases were compensated.&lt;br /&gt;
&lt;br /&gt;
According to documents available with The Hindu , the largest amount in compensation was paid by Sun Pharma. The company paid Rs. 15 lakh in compensation in five cases (Rs. 3 lakh each).&lt;br /&gt;
&lt;br /&gt;
Next in line was US-based Clinical Research Organization (CRO) ICON PLC, (6.52 lakh in three cases), followed by Pfizer Inc (6.5 lakh in two cases) and German pharma and medical-care giant Fresenius (Rs. 1 lakh in two cases).&lt;br /&gt;
&lt;br /&gt;
Delhi-based CRO Apothecaries (Rs. 2.16 lakh), Multinational Clinical Research bigwig Lambda (Rs. 2 lakh), French firm Sanofi (Rs. 1 lakh), and Indian firm Veeda Clinical Research (Rs. 50,000), each paid compensation to one case of death.&lt;br /&gt;
&lt;br /&gt;
The information was provided by the office of the Drug Controller General (India) to medical rights activist, Anand Rai.&lt;br /&gt;
&lt;br /&gt;
The information provided by the DCG (I) doesn&amp;rsquo;t tell if the compensation was paid by the foreign firms or their Indian subsidiaries.&lt;br /&gt;
&lt;br /&gt;
According to official data, between January 2007 and January 2012, Serious Adverse Events (SAEs) during medicine trials killed 2193 people all across India.&lt;br /&gt;
&lt;br /&gt;
The year-wise break-up of the deaths are: 132 (2007), 288 (2008), 637 (2009), 688 (2010), 438 (2011) and 30 (January, 2012).&lt;br /&gt;
&lt;br /&gt;
However, compensation was provided only to 22 victims in 2010 and 16 in 2011.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;It is shocking that only 3 per cent of the cases have been compensated. It is a mockery of the human rights of trial subjects in India. But sadly, the Central Drugs Standard Control Organization&amp;rsquo;s (CDSCO&amp;rsquo;s) new draft guidelines on financial compensation only address part of the problem,&amp;rdquo; says Dr. Rai, who secured the information under the Right to Information Act.&lt;br /&gt;
&lt;br /&gt;
At present, financial compensation isn&amp;rsquo;t mandated by law in India, and is only mentioned as a Good Clinical Practice (GCP) in paragraph 2.4.7 of the Indian Council of Medical Research&amp;rsquo;s GCP Guidelines for Clinical Trials in India.&lt;br /&gt;
&lt;br /&gt;
The CDSCO&amp;rsquo;s new draft guidelines for financial compensation seek to fill this major gap in the existing Drugs and Cosmetic Act, 1940.&lt;br /&gt;
&lt;br /&gt;
The total amount paid in compensation in all the 16 cases in 2011 adds up to Rs. 34.88 lakh&lt;br /&gt;
&lt;br /&gt;
Sun Pharma paid Rs. 15 lakh in compensation in five cases of Rs. 3 lakh each&lt;br /&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu, 19 August, 2012, http://www.thehindu.com/todays-paper/tp-national/article3793837.ece&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;cdsco-drafting-new-norms-for-financial-compensation-mahim-pratap-singh-16654&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 16654,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 16526,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | CDSCO drafting new norms for financial compensation-Mahim Pratap Singh&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Law and Justice,medicines,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Hindu

In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.

The total amount paid in compensation in all the 16 cases...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu&lt;br /&gt;&lt;br /&gt;In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.&lt;br /&gt;&lt;br /&gt;The total amount paid in compensation in all the 16 cases adds up to Rs. 34.88 lakh, with the highest amount being Rs. 5 lakh, and the lowest being Rs. 50,000.&lt;br /&gt;&lt;br /&gt;This makes 2011 only the second year, for which data are available, when any compensation was paid in cases of deaths caused during medicine trials, the previous year being 2010, when 22 such cases were compensated.&lt;br /&gt;&lt;br /&gt;According to documents available with The Hindu , the largest amount in compensation was paid by Sun Pharma. The company paid Rs. 15 lakh in compensation in five cases (Rs. 3 lakh each).&lt;br /&gt;&lt;br /&gt;Next in line was US-based Clinical Research Organization (CRO) ICON PLC, (6.52 lakh in three cases), followed by Pfizer Inc (6.5 lakh in two cases) and German pharma and medical-care giant Fresenius (Rs. 1 lakh in two cases).&lt;br /&gt;&lt;br /&gt;Delhi-based CRO Apothecaries (Rs. 2.16 lakh), Multinational Clinical Research bigwig Lambda (Rs. 2 lakh), French firm Sanofi (Rs. 1 lakh), and Indian firm Veeda Clinical Research (Rs. 50,000), each paid compensation to one case of death.&lt;br /&gt;&lt;br /&gt;The information was provided by the office of the Drug Controller General (India) to medical rights activist, Anand Rai.&lt;br /&gt;&lt;br /&gt;The information provided by the DCG (I) doesn&amp;rsquo;t tell if the compensation was paid by the foreign firms or their Indian subsidiaries.&lt;br /&gt;&lt;br /&gt;According to official data, between January 2007 and January 2012, Serious Adverse Events (SAEs) during medicine trials killed 2193 people all across India.&lt;br /&gt;&lt;br /&gt;The year-wise break-up of the deaths are: 132 (2007), 288 (2008), 637 (2009), 688 (2010), 438 (2011) and 30 (January, 2012).&lt;br /&gt;&lt;br /&gt;However, compensation was provided only to 22 victims in 2010 and 16 in 2011.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;It is shocking that only 3 per cent of the cases have been compensated. It is a mockery of the human rights of trial subjects in India. But sadly, the Central Drugs Standard Control Organization&amp;rsquo;s (CDSCO&amp;rsquo;s) new draft guidelines on financial compensation only address part of the problem,&amp;rdquo; says Dr. Rai, who secured the information under the Right to Information Act.&lt;br /&gt;&lt;br /&gt;At present, financial compensation isn&amp;rsquo;t mandated by law in India, and is only mentioned as a Good Clinical Practice (GCP) in paragraph 2.4.7 of the Indian Council of Medical Research&amp;rsquo;s GCP Guidelines for Clinical Trials in India.&lt;br /&gt;&lt;br /&gt;The CDSCO&amp;rsquo;s new draft guidelines for financial compensation seek to fill this major gap in the existing Drugs and Cosmetic Act, 1940.&lt;br /&gt;&lt;br /&gt;The total amount paid in compensation in all the 16 cases in 2011 adds up to Rs. 34.88 lakh&lt;br /&gt;&lt;br /&gt;Sun Pharma paid Rs. 15 lakh in compensation in five cases of Rs. 3 lakh each&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 16526,
	&#039;title&#039; =&gt; &#039;CDSCO drafting new norms for financial compensation-Mahim Pratap Singh&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu&lt;br /&gt;
&lt;br /&gt;
In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.&lt;br /&gt;
&lt;br /&gt;
The total amount paid in compensation in all the 16 cases adds up to Rs. 34.88 lakh, with the highest amount being Rs. 5 lakh, and the lowest being Rs. 50,000.&lt;br /&gt;
&lt;br /&gt;
This makes 2011 only the second year, for which data are available, when any compensation was paid in cases of deaths caused during medicine trials, the previous year being 2010, when 22 such cases were compensated.&lt;br /&gt;
&lt;br /&gt;
According to documents available with The Hindu , the largest amount in compensation was paid by Sun Pharma. The company paid Rs. 15 lakh in compensation in five cases (Rs. 3 lakh each).&lt;br /&gt;
&lt;br /&gt;
Next in line was US-based Clinical Research Organization (CRO) ICON PLC, (6.52 lakh in three cases), followed by Pfizer Inc (6.5 lakh in two cases) and German pharma and medical-care giant Fresenius (Rs. 1 lakh in two cases).&lt;br /&gt;
&lt;br /&gt;
Delhi-based CRO Apothecaries (Rs. 2.16 lakh), Multinational Clinical Research bigwig Lambda (Rs. 2 lakh), French firm Sanofi (Rs. 1 lakh), and Indian firm Veeda Clinical Research (Rs. 50,000), each paid compensation to one case of death.&lt;br /&gt;
&lt;br /&gt;
The information was provided by the office of the Drug Controller General (India) to medical rights activist, Anand Rai.&lt;br /&gt;
&lt;br /&gt;
The information provided by the DCG (I) doesn&amp;rsquo;t tell if the compensation was paid by the foreign firms or their Indian subsidiaries.&lt;br /&gt;
&lt;br /&gt;
According to official data, between January 2007 and January 2012, Serious Adverse Events (SAEs) during medicine trials killed 2193 people all across India.&lt;br /&gt;
&lt;br /&gt;
The year-wise break-up of the deaths are: 132 (2007), 288 (2008), 637 (2009), 688 (2010), 438 (2011) and 30 (January, 2012).&lt;br /&gt;
&lt;br /&gt;
However, compensation was provided only to 22 victims in 2010 and 16 in 2011.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;It is shocking that only 3 per cent of the cases have been compensated. It is a mockery of the human rights of trial subjects in India. But sadly, the Central Drugs Standard Control Organization&amp;rsquo;s (CDSCO&amp;rsquo;s) new draft guidelines on financial compensation only address part of the problem,&amp;rdquo; says Dr. Rai, who secured the information under the Right to Information Act.&lt;br /&gt;
&lt;br /&gt;
At present, financial compensation isn&amp;rsquo;t mandated by law in India, and is only mentioned as a Good Clinical Practice (GCP) in paragraph 2.4.7 of the Indian Council of Medical Research&amp;rsquo;s GCP Guidelines for Clinical Trials in India.&lt;br /&gt;
&lt;br /&gt;
The CDSCO&amp;rsquo;s new draft guidelines for financial compensation seek to fill this major gap in the existing Drugs and Cosmetic Act, 1940.&lt;br /&gt;
&lt;br /&gt;
The total amount paid in compensation in all the 16 cases in 2011 adds up to Rs. 34.88 lakh&lt;br /&gt;
&lt;br /&gt;
Sun Pharma paid Rs. 15 lakh in compensation in five cases of Rs. 3 lakh each&lt;br /&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu, 19 August, 2012, http://www.thehindu.com/todays-paper/tp-national/article3793837.ece&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;cdsco-drafting-new-norms-for-financial-compensation-mahim-pratap-singh-16654&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 16654,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 16526
$metaTitle = &#039;LATEST NEWS UPDATES | CDSCO drafting new norms for financial compensation-Mahim Pratap Singh&#039;
$metaKeywords = &#039;Law and Justice,medicines,Health&#039;
$metaDesc = &#039;
-The Hindu

In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.

The total amount paid in compensation in all the 16 cases...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu&lt;br /&gt;&lt;br /&gt;In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.&lt;br /&gt;&lt;br /&gt;The total amount paid in compensation in all the 16 cases adds up to Rs. 34.88 lakh, with the highest amount being Rs. 5 lakh, and the lowest being Rs. 50,000.&lt;br /&gt;&lt;br /&gt;This makes 2011 only the second year, for which data are available, when any compensation was paid in cases of deaths caused during medicine trials, the previous year being 2010, when 22 such cases were compensated.&lt;br /&gt;&lt;br /&gt;According to documents available with The Hindu , the largest amount in compensation was paid by Sun Pharma. The company paid Rs. 15 lakh in compensation in five cases (Rs. 3 lakh each).&lt;br /&gt;&lt;br /&gt;Next in line was US-based Clinical Research Organization (CRO) ICON PLC, (6.52 lakh in three cases), followed by Pfizer Inc (6.5 lakh in two cases) and German pharma and medical-care giant Fresenius (Rs. 1 lakh in two cases).&lt;br /&gt;&lt;br /&gt;Delhi-based CRO Apothecaries (Rs. 2.16 lakh), Multinational Clinical Research bigwig Lambda (Rs. 2 lakh), French firm Sanofi (Rs. 1 lakh), and Indian firm Veeda Clinical Research (Rs. 50,000), each paid compensation to one case of death.&lt;br /&gt;&lt;br /&gt;The information was provided by the office of the Drug Controller General (India) to medical rights activist, Anand Rai.&lt;br /&gt;&lt;br /&gt;The information provided by the DCG (I) doesn&amp;rsquo;t tell if the compensation was paid by the foreign firms or their Indian subsidiaries.&lt;br /&gt;&lt;br /&gt;According to official data, between January 2007 and January 2012, Serious Adverse Events (SAEs) during medicine trials killed 2193 people all across India.&lt;br /&gt;&lt;br /&gt;The year-wise break-up of the deaths are: 132 (2007), 288 (2008), 637 (2009), 688 (2010), 438 (2011) and 30 (January, 2012).&lt;br /&gt;&lt;br /&gt;However, compensation was provided only to 22 victims in 2010 and 16 in 2011.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;It is shocking that only 3 per cent of the cases have been compensated. It is a mockery of the human rights of trial subjects in India. But sadly, the Central Drugs Standard Control Organization&amp;rsquo;s (CDSCO&amp;rsquo;s) new draft guidelines on financial compensation only address part of the problem,&amp;rdquo; says Dr. Rai, who secured the information under the Right to Information Act.&lt;br /&gt;&lt;br /&gt;At present, financial compensation isn&amp;rsquo;t mandated by law in India, and is only mentioned as a Good Clinical Practice (GCP) in paragraph 2.4.7 of the Indian Council of Medical Research&amp;rsquo;s GCP Guidelines for Clinical Trials in India.&lt;br /&gt;&lt;br /&gt;The CDSCO&amp;rsquo;s new draft guidelines for financial compensation seek to fill this major gap in the existing Drugs and Cosmetic Act, 1940.&lt;br /&gt;&lt;br /&gt;The total amount paid in compensation in all the 16 cases in 2011 adds up to Rs. 34.88 lakh&lt;br /&gt;&lt;br /&gt;Sun Pharma paid Rs. 15 lakh in compensation in five cases of Rs. 3 lakh each&lt;br /&gt;&lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/cdsco-drafting-new-norms-for-financial-compensation-mahim-pratap-singh-16654.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | CDSCO drafting new norms for financial compensation-Mahim Pratap Singh | Im4change.org</title>
    <meta name="description" content="
-The Hindu

In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.

The total amount paid in compensation in all the 16 cases..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>CDSCO drafting new norms for financial compensation-Mahim Pratap Singh</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Hindu<br /><br />In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.<br /><br />The total amount paid in compensation in all the 16 cases adds up to Rs. 34.88 lakh, with the highest amount being Rs. 5 lakh, and the lowest being Rs. 50,000.<br /><br />This makes 2011 only the second year, for which data are available, when any compensation was paid in cases of deaths caused during medicine trials, the previous year being 2010, when 22 such cases were compensated.<br /><br />According to documents available with The Hindu , the largest amount in compensation was paid by Sun Pharma. The company paid Rs. 15 lakh in compensation in five cases (Rs. 3 lakh each).<br /><br />Next in line was US-based Clinical Research Organization (CRO) ICON PLC, (6.52 lakh in three cases), followed by Pfizer Inc (6.5 lakh in two cases) and German pharma and medical-care giant Fresenius (Rs. 1 lakh in two cases).<br /><br />Delhi-based CRO Apothecaries (Rs. 2.16 lakh), Multinational Clinical Research bigwig Lambda (Rs. 2 lakh), French firm Sanofi (Rs. 1 lakh), and Indian firm Veeda Clinical Research (Rs. 50,000), each paid compensation to one case of death.<br /><br />The information was provided by the office of the Drug Controller General (India) to medical rights activist, Anand Rai.<br /><br />The information provided by the DCG (I) doesn&rsquo;t tell if the compensation was paid by the foreign firms or their Indian subsidiaries.<br /><br />According to official data, between January 2007 and January 2012, Serious Adverse Events (SAEs) during medicine trials killed 2193 people all across India.<br /><br />The year-wise break-up of the deaths are: 132 (2007), 288 (2008), 637 (2009), 688 (2010), 438 (2011) and 30 (January, 2012).<br /><br />However, compensation was provided only to 22 victims in 2010 and 16 in 2011.<br /><br />&ldquo;It is shocking that only 3 per cent of the cases have been compensated. It is a mockery of the human rights of trial subjects in India. But sadly, the Central Drugs Standard Control Organization&rsquo;s (CDSCO&rsquo;s) new draft guidelines on financial compensation only address part of the problem,&rdquo; says Dr. Rai, who secured the information under the Right to Information Act.<br /><br />At present, financial compensation isn&rsquo;t mandated by law in India, and is only mentioned as a Good Clinical Practice (GCP) in paragraph 2.4.7 of the Indian Council of Medical Research&rsquo;s GCP Guidelines for Clinical Trials in India.<br /><br />The CDSCO&rsquo;s new draft guidelines for financial compensation seek to fill this major gap in the existing Drugs and Cosmetic Act, 1940.<br /><br />The total amount paid in compensation in all the 16 cases in 2011 adds up to Rs. 34.88 lakh<br /><br />Sun Pharma paid Rs. 15 lakh in compensation in five cases of Rs. 3 lakh each<br /><br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 16526,
		'title' => 'CDSCO drafting new norms for financial compensation-Mahim Pratap Singh',
		'subheading' => '',
		'description' => '<div align="justify">
-The Hindu<br />
<br />
In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.<br />
<br />
The total amount paid in compensation in all the 16 cases adds up to Rs. 34.88 lakh, with the highest amount being Rs. 5 lakh, and the lowest being Rs. 50,000.<br />
<br />
This makes 2011 only the second year, for which data are available, when any compensation was paid in cases of deaths caused during medicine trials, the previous year being 2010, when 22 such cases were compensated.<br />
<br />
According to documents available with The Hindu , the largest amount in compensation was paid by Sun Pharma. The company paid Rs. 15 lakh in compensation in five cases (Rs. 3 lakh each).<br />
<br />
Next in line was US-based Clinical Research Organization (CRO) ICON PLC, (6.52 lakh in three cases), followed by Pfizer Inc (6.5 lakh in two cases) and German pharma and medical-care giant Fresenius (Rs. 1 lakh in two cases).<br />
<br />
Delhi-based CRO Apothecaries (Rs. 2.16 lakh), Multinational Clinical Research bigwig Lambda (Rs. 2 lakh), French firm Sanofi (Rs. 1 lakh), and Indian firm Veeda Clinical Research (Rs. 50,000), each paid compensation to one case of death.<br />
<br />
The information was provided by the office of the Drug Controller General (India) to medical rights activist, Anand Rai.<br />
<br />
The information provided by the DCG (I) doesn&rsquo;t tell if the compensation was paid by the foreign firms or their Indian subsidiaries.<br />
<br />
According to official data, between January 2007 and January 2012, Serious Adverse Events (SAEs) during medicine trials killed 2193 people all across India.<br />
<br />
The year-wise break-up of the deaths are: 132 (2007), 288 (2008), 637 (2009), 688 (2010), 438 (2011) and 30 (January, 2012).<br />
<br />
However, compensation was provided only to 22 victims in 2010 and 16 in 2011.<br />
<br />
&ldquo;It is shocking that only 3 per cent of the cases have been compensated. It is a mockery of the human rights of trial subjects in India. But sadly, the Central Drugs Standard Control Organization&rsquo;s (CDSCO&rsquo;s) new draft guidelines on financial compensation only address part of the problem,&rdquo; says Dr. Rai, who secured the information under the Right to Information Act.<br />
<br />
At present, financial compensation isn&rsquo;t mandated by law in India, and is only mentioned as a Good Clinical Practice (GCP) in paragraph 2.4.7 of the Indian Council of Medical Research&rsquo;s GCP Guidelines for Clinical Trials in India.<br />
<br />
The CDSCO&rsquo;s new draft guidelines for financial compensation seek to fill this major gap in the existing Drugs and Cosmetic Act, 1940.<br />
<br />
The total amount paid in compensation in all the 16 cases in 2011 adds up to Rs. 34.88 lakh<br />
<br />
Sun Pharma paid Rs. 15 lakh in compensation in five cases of Rs. 3 lakh each<br />
<br />
</div>',
		'credit_writer' => 'The Hindu, 19 August, 2012, http://www.thehindu.com/todays-paper/tp-national/article3793837.ece',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'cdsco-drafting-new-norms-for-financial-compensation-mahim-pratap-singh-16654',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 16654,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 16526,
	'metaTitle' => 'LATEST NEWS UPDATES | CDSCO drafting new norms for financial compensation-Mahim Pratap Singh',
	'metaKeywords' => 'Law and Justice,medicines,Health',
	'metaDesc' => '
-The Hindu

In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.

The total amount paid in compensation in all the 16 cases...',
	'disp' => '<div align="justify">-The Hindu<br /><br />In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.<br /><br />The total amount paid in compensation in all the 16 cases adds up to Rs. 34.88 lakh, with the highest amount being Rs. 5 lakh, and the lowest being Rs. 50,000.<br /><br />This makes 2011 only the second year, for which data are available, when any compensation was paid in cases of deaths caused during medicine trials, the previous year being 2010, when 22 such cases were compensated.<br /><br />According to documents available with The Hindu , the largest amount in compensation was paid by Sun Pharma. The company paid Rs. 15 lakh in compensation in five cases (Rs. 3 lakh each).<br /><br />Next in line was US-based Clinical Research Organization (CRO) ICON PLC, (6.52 lakh in three cases), followed by Pfizer Inc (6.5 lakh in two cases) and German pharma and medical-care giant Fresenius (Rs. 1 lakh in two cases).<br /><br />Delhi-based CRO Apothecaries (Rs. 2.16 lakh), Multinational Clinical Research bigwig Lambda (Rs. 2 lakh), French firm Sanofi (Rs. 1 lakh), and Indian firm Veeda Clinical Research (Rs. 50,000), each paid compensation to one case of death.<br /><br />The information was provided by the office of the Drug Controller General (India) to medical rights activist, Anand Rai.<br /><br />The information provided by the DCG (I) doesn&rsquo;t tell if the compensation was paid by the foreign firms or their Indian subsidiaries.<br /><br />According to official data, between January 2007 and January 2012, Serious Adverse Events (SAEs) during medicine trials killed 2193 people all across India.<br /><br />The year-wise break-up of the deaths are: 132 (2007), 288 (2008), 637 (2009), 688 (2010), 438 (2011) and 30 (January, 2012).<br /><br />However, compensation was provided only to 22 victims in 2010 and 16 in 2011.<br /><br />&ldquo;It is shocking that only 3 per cent of the cases have been compensated. It is a mockery of the human rights of trial subjects in India. But sadly, the Central Drugs Standard Control Organization&rsquo;s (CDSCO&rsquo;s) new draft guidelines on financial compensation only address part of the problem,&rdquo; says Dr. Rai, who secured the information under the Right to Information Act.<br /><br />At present, financial compensation isn&rsquo;t mandated by law in India, and is only mentioned as a Good Clinical Practice (GCP) in paragraph 2.4.7 of the Indian Council of Medical Research&rsquo;s GCP Guidelines for Clinical Trials in India.<br /><br />The CDSCO&rsquo;s new draft guidelines for financial compensation seek to fill this major gap in the existing Drugs and Cosmetic Act, 1940.<br /><br />The total amount paid in compensation in all the 16 cases in 2011 adds up to Rs. 34.88 lakh<br /><br />Sun Pharma paid Rs. 15 lakh in compensation in five cases of Rs. 3 lakh each<br /><br /></div>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 16526,
	'title' => 'CDSCO drafting new norms for financial compensation-Mahim Pratap Singh',
	'subheading' => '',
	'description' => '<div align="justify">
-The Hindu<br />
<br />
In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.<br />
<br />
The total amount paid in compensation in all the 16 cases adds up to Rs. 34.88 lakh, with the highest amount being Rs. 5 lakh, and the lowest being Rs. 50,000.<br />
<br />
This makes 2011 only the second year, for which data are available, when any compensation was paid in cases of deaths caused during medicine trials, the previous year being 2010, when 22 such cases were compensated.<br />
<br />
According to documents available with The Hindu , the largest amount in compensation was paid by Sun Pharma. The company paid Rs. 15 lakh in compensation in five cases (Rs. 3 lakh each).<br />
<br />
Next in line was US-based Clinical Research Organization (CRO) ICON PLC, (6.52 lakh in three cases), followed by Pfizer Inc (6.5 lakh in two cases) and German pharma and medical-care giant Fresenius (Rs. 1 lakh in two cases).<br />
<br />
Delhi-based CRO Apothecaries (Rs. 2.16 lakh), Multinational Clinical Research bigwig Lambda (Rs. 2 lakh), French firm Sanofi (Rs. 1 lakh), and Indian firm Veeda Clinical Research (Rs. 50,000), each paid compensation to one case of death.<br />
<br />
The information was provided by the office of the Drug Controller General (India) to medical rights activist, Anand Rai.<br />
<br />
The information provided by the DCG (I) doesn&rsquo;t tell if the compensation was paid by the foreign firms or their Indian subsidiaries.<br />
<br />
According to official data, between January 2007 and January 2012, Serious Adverse Events (SAEs) during medicine trials killed 2193 people all across India.<br />
<br />
The year-wise break-up of the deaths are: 132 (2007), 288 (2008), 637 (2009), 688 (2010), 438 (2011) and 30 (January, 2012).<br />
<br />
However, compensation was provided only to 22 victims in 2010 and 16 in 2011.<br />
<br />
&ldquo;It is shocking that only 3 per cent of the cases have been compensated. It is a mockery of the human rights of trial subjects in India. But sadly, the Central Drugs Standard Control Organization&rsquo;s (CDSCO&rsquo;s) new draft guidelines on financial compensation only address part of the problem,&rdquo; says Dr. Rai, who secured the information under the Right to Information Act.<br />
<br />
At present, financial compensation isn&rsquo;t mandated by law in India, and is only mentioned as a Good Clinical Practice (GCP) in paragraph 2.4.7 of the Indian Council of Medical Research&rsquo;s GCP Guidelines for Clinical Trials in India.<br />
<br />
The CDSCO&rsquo;s new draft guidelines for financial compensation seek to fill this major gap in the existing Drugs and Cosmetic Act, 1940.<br />
<br />
The total amount paid in compensation in all the 16 cases in 2011 adds up to Rs. 34.88 lakh<br />
<br />
Sun Pharma paid Rs. 15 lakh in compensation in five cases of Rs. 3 lakh each<br />
<br />
</div>',
	'credit_writer' => 'The Hindu, 19 August, 2012, http://www.thehindu.com/todays-paper/tp-national/article3793837.ece',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'cdsco-drafting-new-norms-for-financial-compensation-mahim-pratap-singh-16654',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 16654,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 16526
$metaTitle = 'LATEST NEWS UPDATES | CDSCO drafting new norms for financial compensation-Mahim Pratap Singh'
$metaKeywords = 'Law and Justice,medicines,Health'
$metaDesc = '
-The Hindu

In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.

The total amount paid in compensation in all the 16 cases...'
$disp = '<div align="justify">-The Hindu<br /><br />In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases.<br /><br />The total amount paid in compensation in all the 16 cases adds up to Rs. 34.88 lakh, with the highest amount being Rs. 5 lakh, and the lowest being Rs. 50,000.<br /><br />This makes 2011 only the second year, for which data are available, when any compensation was paid in cases of deaths caused during medicine trials, the previous year being 2010, when 22 such cases were compensated.<br /><br />According to documents available with The Hindu , the largest amount in compensation was paid by Sun Pharma. The company paid Rs. 15 lakh in compensation in five cases (Rs. 3 lakh each).<br /><br />Next in line was US-based Clinical Research Organization (CRO) ICON PLC, (6.52 lakh in three cases), followed by Pfizer Inc (6.5 lakh in two cases) and German pharma and medical-care giant Fresenius (Rs. 1 lakh in two cases).<br /><br />Delhi-based CRO Apothecaries (Rs. 2.16 lakh), Multinational Clinical Research bigwig Lambda (Rs. 2 lakh), French firm Sanofi (Rs. 1 lakh), and Indian firm Veeda Clinical Research (Rs. 50,000), each paid compensation to one case of death.<br /><br />The information was provided by the office of the Drug Controller General (India) to medical rights activist, Anand Rai.<br /><br />The information provided by the DCG (I) doesn&rsquo;t tell if the compensation was paid by the foreign firms or their Indian subsidiaries.<br /><br />According to official data, between January 2007 and January 2012, Serious Adverse Events (SAEs) during medicine trials killed 2193 people all across India.<br /><br />The year-wise break-up of the deaths are: 132 (2007), 288 (2008), 637 (2009), 688 (2010), 438 (2011) and 30 (January, 2012).<br /><br />However, compensation was provided only to 22 victims in 2010 and 16 in 2011.<br /><br />&ldquo;It is shocking that only 3 per cent of the cases have been compensated. It is a mockery of the human rights of trial subjects in India. But sadly, the Central Drugs Standard Control Organization&rsquo;s (CDSCO&rsquo;s) new draft guidelines on financial compensation only address part of the problem,&rdquo; says Dr. Rai, who secured the information under the Right to Information Act.<br /><br />At present, financial compensation isn&rsquo;t mandated by law in India, and is only mentioned as a Good Clinical Practice (GCP) in paragraph 2.4.7 of the Indian Council of Medical Research&rsquo;s GCP Guidelines for Clinical Trials in India.<br /><br />The CDSCO&rsquo;s new draft guidelines for financial compensation seek to fill this major gap in the existing Drugs and Cosmetic Act, 1940.<br /><br />The total amount paid in compensation in all the 16 cases in 2011 adds up to Rs. 34.88 lakh<br /><br />Sun Pharma paid Rs. 15 lakh in compensation in five cases of Rs. 3 lakh each<br /><br /></div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

CDSCO drafting new norms for financial compensation-Mahim Pratap Singh

-The Hindu In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases. The total amount paid in compensation in all the 16 cases adds up to Rs. 34.88 lakh, with the highest amount being Rs. 5 lakh, and the lowest being Rs. 50,000. This makes 2011 only the second year, for which data are available, when any compensation was paid in cases of deaths caused during medicine trials, the previous year being 2010, when 22 such cases were compensated. According to documents available with The Hindu , the largest amount in compensation was paid by Sun Pharma. The company paid Rs. 15 lakh in compensation in five cases (Rs. 3 lakh each). Next in line was US-based Clinical Research Organization (CRO) ICON PLC, (6.52 lakh in three cases), followed by Pfizer Inc (6.5 lakh in two cases) and German pharma and medical-care giant Fresenius (Rs. 1 lakh in two cases). Delhi-based CRO Apothecaries (Rs. 2.16 lakh), Multinational Clinical Research bigwig Lambda (Rs. 2 lakh), French firm Sanofi (Rs. 1 lakh), and Indian firm Veeda Clinical Research (Rs. 50,000), each paid compensation to one case of death. The information was provided by the office of the Drug Controller General (India) to medical rights activist, Anand Rai. The information provided by the DCG (I) doesn’t tell if the compensation was paid by the foreign firms or their Indian subsidiaries. According to official data, between January 2007 and January 2012, Serious Adverse Events (SAEs) during medicine trials killed 2193 people all across India. The year-wise break-up of the deaths are: 132 (2007), 288 (2008), 637 (2009), 688 (2010), 438 (2011) and 30 (January, 2012). However, compensation was provided only to 22 victims in 2010 and 16 in 2011. “It is shocking that only 3 per cent of the cases have been compensated. It is a mockery of the human rights of trial subjects in India. But sadly, the Central Drugs Standard Control Organization’s (CDSCO’s) new draft guidelines on financial compensation only address part of the problem,” says Dr. Rai, who secured the information under the Right to Information Act. At present, financial compensation isn’t mandated by law in India, and is only mentioned as a Good Clinical Practice (GCP) in paragraph 2.4.7 of the Indian Council of Medical Research’s GCP Guidelines for Clinical Trials in India. The CDSCO’s new draft guidelines for financial compensation seek to fill this major gap in the existing Drugs and Cosmetic Act, 1940. The total amount paid in compensation in all the 16 cases in 2011 adds up to Rs. 34.88 lakh Sun Pharma paid Rs. 15 lakh in compensation in five cases of Rs. 3 lakh each